Solid Dispersion

Abstract Poor water solubility is an important challenge in the development of oral patient-friendly solid dosage forms. This study aimed...

The Poster was presented at CMAC Summer School 2024 Context and Aim of Work This study utilised the HUB Additive-ManufacturingMicroFactory...

In this study, we investigated the formulation of stable solid dispersions to enhance the bioavailability of olaparib (OLA), a therapeutic...

Nintedanib, a primary treatment for lung fibrosis, has gathered substantial attention due to its multifaceted potential. A tyrosine kinase inhibitor,...

OVERVIEW Sulindac is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain and help relieve symptoms of...

Abstract Amorphous solid dispersion (ASD) has emerged to be an outstanding strategy among multiple options available for improving solubility and...

Abstract Colon-targeted drug delivery continues to generate increasing attention for its prospects in treating inflammatory bowel disease (IBD). This study...

Abstract PROTACs, proteolysis targeting chimeras, are bifunctional molecules inducing protein degradation through a unique proximity-based mode of action. While offering...

Berberine is used in the treatment of metabolic syndrome and its low solubility and very poor oral bioavailability of berberine...

The quantification of both polymer and drug during the dissolution of an amorphous solid dispersion (ASD) in aqueous media arouses...